ADRA2A
adrenoceptor alpha 2A | ADRAR, ADRA2, ADRA2R

Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. The alpha-2-adrenergic receptors are a type of adrenergic receptors (for adrenaline or epinephrine), which inhibit adenylate cyclase. These receptors include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. They are involved in regulating the release of neurotransmitter molecules from sympathetic nerves and from adrenergic neurons in the central nervous system. The sympathetic nervous system regulates cardiovascular function by activating adrenergic receptors in the heart, blood vessels and kidney. Studies in mouse revealed that both the alpha2A and alpha2C receptor subtypes were required for presynaptic transmitter release from the sympathetic nervous system in the heart and from central noradrenergic neurons. The alpha-2-adrenergic receptors are also involved in catecholamine signaling by extracellular regulated protein kinase 1 and 2 (ERK1/2) pathways. A clear association between the alpha-2-adrenergic receptor and disease has not been yet established. [provided by RefSeq, Sep 2019]

Biological processes 88 terms
DNA replication (GO:0006260)G protein-coupled receptor activity (GO:0004930)G protein-coupled receptor signaling pathway (GO:0007186)G protein-coupled receptor signaling pathway (GO:0007186)G protein-coupled receptor signaling pathway (GO:0007186)GABA-ergic synapse (GO:0098982)Ras protein signal transduction (GO:0007265)Rho protein signal transduction (GO:0007266)actin cytoskeleton organization (GO:0030036)adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)adrenergic receptor activity (GO:0004935)adrenergic receptor signaling pathway (GO:0071875)alpha-1B adrenergic receptor binding (GO:0031692)alpha-2C adrenergic receptor binding (GO:0031696)alpha2-adrenergic receptor activity (GO:0004938)alpha2-adrenergic receptor activity (GO:0004938)alpha2-adrenergic receptor activity (GO:0004938)alpha2-adrenergic receptor activity (GO:0004938)alpha2-adrenergic receptor activity (GO:0004938)alpha2-adrenergic receptor activity (GO:0004938)axon terminus (GO:0043679)basolateral plasma membrane (GO:0016323)cellular response to hormone stimulus (GO:0032870)cytoplasm (GO:0005737)dopaminergic synapse (GO:0098691)epidermal growth factor receptor signaling pathway (GO:0007173)epinephrine binding (GO:0051379)epinephrine binding (GO:0051379)female pregnancy (GO:0007565)glucose homeostasis (GO:0042593)glucose homeostasis (GO:0042593)glutamatergic synapse (GO:0098978)heterotrimeric G-protein binding (GO:0032795)intestinal absorption (GO:0050892)membrane (GO:0016020)negative regulation of calcium ion transport (GO:0051926)negative regulation of calcium ion-dependent exocytosis (GO:0045955)negative regulation of calcium ion-dependent exocytosis (GO:0045955)negative regulation of epinephrine secretion (GO:0032811)negative regulation of insulin secretion (GO:0046676)negative regulation of insulin secretion (GO:0046676)negative regulation of insulin secretion (GO:0046676)negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)negative regulation of lipid catabolic process (GO:0050995)negative regulation of norepinephrine secretion (GO:0010700)negative regulation of norepinephrine secretion (GO:0010700)negative regulation of norepinephrine secretion (GO:0010700)negative regulation of norepinephrine secretion (GO:0010700)negative regulation of uterine smooth muscle contraction (GO:0070473)neuronal cell body (GO:0043025)norepinephrine binding (GO:0051380)phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)plasma membrane (GO:0005886)plasma membrane (GO:0005886)plasma membrane (GO:0005886)plasma membrane (GO:0005886)plasma membrane (GO:0005886)platelet activation (GO:0030168)positive regulation of MAPK cascade (GO:0043410)positive regulation of cell migration (GO:0030335)positive regulation of cell population proliferation (GO:0008284)positive regulation of cytokine production (GO:0001819)positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)positive regulation of membrane protein ectodomain proteolysis (GO:0051044)positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0051897)positive regulation of potassium ion transport (GO:0043268)positive regulation of wound healing (GO:0090303)postsynaptic density membrane (GO:0098839)postsynaptic membrane (GO:0045211)presynaptic active zone membrane (GO:0048787)presynaptic modulation of chemical synaptic transmission (GO:0099171)protein binding (GO:0005515)protein homodimerization activity (GO:0042803)protein kinase binding (GO:0019901)regulation of smooth muscle contraction (GO:0006940)regulation of vasoconstriction (GO:0019229)response to alcohol (GO:0097305)response to morphine (GO:0043278)signaling receptor complex (GO:0043235)thermoception (GO:0050955)thioesterase binding (GO:0031996)vasodilation (GO:0042311)
Expression (TPM)
ADRA2A — as a Regulated Gene

TFs regulating ADRA2A 0 TFs

Transcription factors with Perturb-seq knockdown data for ADRA2A. The Binding column indicates whether any binding evidence exists for this TF–gene pair (ChIP-seq or motif footprint peaks). The Mean coef is the average Perturb-seq regression coefficient across active gRNAs (positive = ADRA2A upregulated upon KD; negative = downregulated). The Outlier column indicates whether this gene is in the top or bottom 5% of all TF knockdown effects.

Data: Effect:
TF Mean coef Binding Outlier TF→Gene link

Elements linked to ADRA2A

Open chromatin peaks (ATAC-seq) in the genomic neighbourhood of ADRA2A, linked by TSS proximity or chromatin conformation (Multiome / HiCAR). Each element overlaps at least one TF ChIP-seq binding site — the TFs column shows how many distinct TFs bind that element.

Accessibility Element Dist. to TSS Link type TFs
chr10:111,075,793–111,079,438 at TSS At TSS 555

Genome Browser

Genomic view of the ADRA2A locus showing ATAC-seq accessibility and RNA-seq expression across the ESC → DE time course, together with TF binding peaks and element-to-TSS loop connections.

chr10:111,065,793 – 111,089,438
Proximal 1 kb Distal 10 kb Multiome HiCAR ATAC-seq RNA-seq